NewSpring Ventures
NewSpring Ventures is the venture capital arm of NewSpring Capital, focusing on providing capital for growth, expansion, recapitalizations, and venture buyouts to businesses in the Mid-Atlantic region of the United States. The fund primarily invests in companies involved in enabling technology, business services, and information technology. The investment team possesses over 60 years of combined experience in venture capital, investment banking, finance, accounting, and operations. Many team members have held senior management roles and have founded or co-founded multiple companies. This operational background enhances their ability to add value to portfolio companies and limited partners through professionalized investment processes and strong corporate governance. NewSpring Ventures has raised and managed several funds, maintains co-investment relationships with over 50 venture fund families, and has engaged with more than 100 portfolio companies over the past 14 years, achieving 32 positive liquidity events. The firm distinguishes itself through its deep operational and investment experience, proprietary deal flow, creative structuring of deals, diligent oversight of investments, and a robust regional network that facilitates deal flow and management recruitment.
14 past transactions
NitroSecurity
Venture Round in 2010
NitroSecurity specializes in providing Unified Information Security solutions designed to enhance network security for enterprises across various sectors, including healthcare, education, financial services, government, retail, and hospitality. The company utilizes patented data management technology to deliver a comprehensive suite of integrated security products. These offerings include security information and event management, log management, database activity monitoring, network analysis, and intrusion prevention. Key products from NitroSecurity include NitroView Enterprise Security Manager, NitroView LogCaster, and NitroGuard, all aimed at protecting business information and infrastructure while ensuring compliance and security in an increasingly complex digital landscape.
NitroSecurity
Series D in 2008
NitroSecurity specializes in providing Unified Information Security solutions designed to enhance network security for enterprises across various sectors, including healthcare, education, financial services, government, retail, and hospitality. The company utilizes patented data management technology to deliver a comprehensive suite of integrated security products. These offerings include security information and event management, log management, database activity monitoring, network analysis, and intrusion prevention. Key products from NitroSecurity include NitroView Enterprise Security Manager, NitroView LogCaster, and NitroGuard, all aimed at protecting business information and infrastructure while ensuring compliance and security in an increasingly complex digital landscape.
BlueNog
Series A in 2008
Bluenog Corporation is an enterprise software and solutions company based in Somerset, New Jersey, founded in 2006. It specializes in providing information technology services focused on Oracle technologies, with expertise in areas such as service-oriented architecture, information management, content management, and business intelligence. Bluenog offers a range of services, including implementation and support, and serves various industries, including healthcare, finance, retail, and telecommunications. The company develops software designed to connect front-end systems with back-end applications, enhancing operational efficiency and facilitating seamless integration with third-party applications. By leveraging Web 2.0 technologies, Bluenog accelerates enterprise application development and fosters collaboration within organizations.
EKR Therapeutics
Series B in 2006
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.
Sopherion Therapeutics
Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.
Othera Pharmaceuticals
Series B in 2004
Othera Pharmaceuticals, Inc. is a specialty pharmaceutical company headquartered in Exton, Pennsylvania, that specializes in the development of proprietary treatments for ophthalmic diseases. Founded in 2002, the company is focused on innovative therapies that address significant unmet medical needs in eye health. Its product portfolio includes OT-551, designed for geographic atrophy and dry age-related macular degeneration, OT-730, a small molecule oculoselective beta-blocker aimed at reducing elevated intraocular pressure in glaucoma patients, and OT-440, a neuroprotectant intended to provide protection against glaucoma-related damage. Othera Pharmaceuticals is dedicated to advancing the field of ophthalmology through its targeted drug development initiatives.
CorrectNet
Series B in 2004
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for major investment management firms. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. Its services are facilitated through the InfiPOINT platform, which enhances client reporting capabilities, and the Advisor WebTools portal designed for wealth advisors and registered investment advisors. CorrectNet is known for its ability to meet stringent transparency and reporting standards, serving a diverse clientele that includes hedge funds, funds of funds, fund administrators, and prime brokers. The company's expertise ensures that investors, portfolio managers, operations teams, and executives receive comprehensive and timely reporting through advanced web portals.
Fiberlink
Series C in 2003
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
CorrectNet
Series A in 2001
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for major investment management firms. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. Its services are facilitated through the InfiPOINT platform, which enhances client reporting capabilities, and the Advisor WebTools portal designed for wealth advisors and registered investment advisors. CorrectNet is known for its ability to meet stringent transparency and reporting standards, serving a diverse clientele that includes hedge funds, funds of funds, fund administrators, and prime brokers. The company's expertise ensures that investors, portfolio managers, operations teams, and executives receive comprehensive and timely reporting through advanced web portals.
Ripple Technologies
Series B in 2001
Ripple Technologies is a company that specializes in data access and database monitoring solutions, providing tools that enhance security and operational efficiency for enterprise environments. Its flagship products include RippleTech Informant, which monitors and analyzes data access trends to identify potential security risks, and RippleTech LogCaster, designed for log and event management to facilitate application access monitoring and compliance auditing. The company caters to a diverse range of sectors, including finance, telecommunications, healthcare, technology, manufacturing, pharmaceuticals, government, and educational institutions. Founded in 1998 and headquartered in Conshohocken, Pennsylvania, Ripple Technologies has established strategic partnerships with major industry players such as IBM, Microsoft, MySQL Enterprise, and Oracle. As of July 2008, Ripple Technologies operates as a subsidiary of NitroSecurity.
Step 9 Software
Series B in 2000
Step 9 Software offers web-enabled, pre-integrated operational support systems for communication providers.
iSun Networks
Series A in 2000
iSun Networks is a U.S.-based company founded in 2000 by Byron Guernsey, specializing in software infrastructure designed to enhance interaction among affinity groups, particularly within educational institutions. The company develops software that enables colleges and universities to create customizable and dynamic virtual communities tailored to specific interests. By focusing on technology and content, iSun Networks supports these communities, providing clients with an engaging platform that fosters interaction and connectivity. Its approach allows educational organizations to leverage a graphical environment for better engagement and collaboration among their members.
Omnient Corporation
Series A in 2000
Teaming with you, Omnient provides one-stop solutions for all of your e-business and e-commerce needs. They explore your vision and analyze your options, making sense of internet technology and mapping the best routes. They help you plan for growth... and the unexpected.
Fiberlink
Venture Round in 2000
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.